Takeda’s dengue vaccine QDENGA has received approval from India’s drug regulator, making it the first dengue vaccine approved in the country. The milestone opens a new commercial market for Takeda in India and supports positive growth expectations for its dengue franchise.
Takeda’s dengue vaccine QDENGA has received approval from India’s drug regulator, making it the first dengue vaccine approved in the country. The milestone opens a new commercial market for Takeda in India and supports positive growth expectations for its dengue franchise.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
